^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AB-101

    i
    Other names: AB-101
    Associations

    News

    Trials
    Company:
    Arbutus
    Drug class:
    PD-L1 inhibitor
    Related drugs:
    Associations

    News

    Trials
    3ms
    Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects. (clinicaltrials.gov)
    P1, N=164, Recruiting, Arbutus Biopharma Corporation | Not yet recruiting --> Recruiting
    Enrollment open
    |
    AB-101